ArticleScientific reports2026
Elevated neutrophil-to-lymphocyte ratio and the incidence of autoimmune diseases: evidence from a large prospective cohort study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Long-term anakinra therapy in Schnitzler syndrome: real-world evidence on remission of neutrophilic dermatitis and systemic inflammation, safety, biomarker insights and dose optimization.Frontiers in immunology · 2026Observational
- Peripheral blood inflammatory indices across thyroid functional states in Graves' disease: associations with liver biochemical abnormalities and hyperthyroid relapse.Frontiers in endocrinology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
We prospectively assessed the association between neutrophil-to-lymphocyte ratio (NLR) and incident autoimmune disease risk using data from 430,347 UK Biobank participants recruited between 2006 and 2010. The NLR was calculated by dividing neutrophil counts by lymphocyte counts and categorized into quartiles. Cox regression models estimated hazard ratios (HRs) for per quartile increase of (1) a composite of 39 types of autoimmune diseases, (2) each specific autoimmune diseases, applying a 2-year lag-period and Bonferroni adjustments. Natural cubic spline analysis was performed to assess the threshold of NLR associated with autoimmune diseases. Among 430,347 participants (mean age: 56.4 years, 53.9% female), elevated NLR was significantly associated with any autoimmune diseases (27,571 events, HR per quartile increase: 1.09, 95% CI: 1.08-1.10; P-trend < 0.01). A non-linear association was observed, with risk significantly increasing above an NLR threshold of 2.51. Participants in the highest quartile (Q4) had a higher risk compared to Q1 (HR 1.30, 95% CI 1.26-1.35). Of 39 autoimmune diseases, 14 showed significant associations, most notably sarcoidosis (HR 1.52, 95% CI 1.38-1.67), antiphospholipid syndrome (1.46, 1.26-1.69), and autoimmune hepatitis (1.37, 1.20-1.56). These findings suggest elevated NLR as a potential pre-clinical indicator for identifying individuals at increased risk of autoimmune diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.